Period Ending | Jun 29, 2012 | Mar 30, 2012 | Dec 30, 2011 | Sep 29, 2011 |
---|
Total Revenue
|
7,534,000
|
7,486,000
|
7,089,000
|
7,531,000
| Cost of Revenue | 3,870,000 | 3,889,000 | 3,824,000 | 4,027,000 | |
Gross Profit
|
3,664,000
|
3,597,000
|
3,265,000
|
3,504,000
| |
|
Operating Expenses |
|
Research Development | 408,000 | 411,000 | 379,000 | 389,000 |
|
Selling General and Administrative | 1,528,000 | 1,552,000 | 1,522,000 | 1,534,000 |
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | |
Operating Income or Loss
|
1,728,000
|
1,634,000
|
1,364,000
|
1,581,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 10,000 | 9,000 | 10,000 | 10,000 |
|
Earnings Before Interest And Taxes | 1,738,000 | 1,643,000 | 1,374,000 | 1,591,000 |
|
Interest Expense | 43,000 | 40,000 | 45,000 | 48,000 |
|
Income Before Tax | 1,695,000 | 1,603,000 | 1,329,000 | 1,543,000 |
|
Income Tax Expense | 509,000 | 462,000 | 355,000 | 440,000 |
|
Minority Interest | (19,000) | (16,000) | (20,000) | (15,000) |
|
|
|
Net Income From Continuing Ops | 1,167,000 | 1,125,000 | 954,000 | 1,088,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | |
Net Income
|
1,167,000
|
1,125,000
|
954,000
|
1,088,000
| Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| |
Net Income Applicable To Common Shares
|
1,167,000
|
1,125,000
|
954,000
|
1,088,000
|
|